<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37255981</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>The impact that myocarditis for post-acute COVID-19 syndrome may be dermatomyositis-like myocarditis: A case report.</ArticleTitle><Pagination><StartPage>e16512</StartPage><MedlinePgn>e16512</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e16512</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2023.e16512</ELocationID><Abstract><AbstractText>Myocarditis is often reported as a complication of COVID-19 infection or post-vaccination, but there are few reports of "myocarditis for Post-acute COVID-19 syndrome", and many unknowns still remain. Apart from that, an association between COVID-19 infection and dermatomyositis has also been reported. We describe the clinical presentation of acute myocarditis in a patient who had developed COVID-19 syndrome one-month earlier. A healthy 49-year-old man experienced typical COVID-19 symptoms. Thirty-two days later, he was admitted because of fever and severe fatigue, chest pain and bradycardia. Blood tests showed major inflammation. PCR for SARS-CoV-2 on nasopharyngeal swab (ID NOW&#x2122;) was positive, but diagnosed as a previous infection due to a high CT value. Because of haemodynamic worsening with both an increase in cardiac troponin I and NT-pro BNP levels and reduced wall motion on echocardiography, acute myocarditis was suspected. Myocardial biopsy revealed severe lymphocytic infiltration and interstitial edema between myocardial fibers. These findings led to the diagnosis of fulminant myocarditis. Interestingly, myocardium was also stained with human myxovirus resistance protein 1 (MxA). We consider that there may be an aspect of "dermatomyositis-like myocarditis with SARS-CoV-2" in our case. This is the first case of fulminant myocarditis for Post-acute COVID-19 syndrome in which diagnosis of active myocarditis was proven by pathological examination following myocardial biopsy and strong association with dermatomyositis was suggested pathologically.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Haruyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurashige</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuda</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Clinical Training Center, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Shiori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanegawa</LastName><ForeName>Munehiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumimoto</LastName><ForeName>Yoji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masada</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimonaga</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugino</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dermatomyositis</Keyword><Keyword MajorTopicYN="N">Fulminant myocarditis</Keyword><Keyword MajorTopicYN="N">Human myxovirus resistance protein 1 (MxA)</Keyword><Keyword MajorTopicYN="N">Long COVID-19-associated myocarditis</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37255981</ArticleId><ArticleId IdType="pmc">PMC10212591</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2023.e16512</ArticleId><ArticleId IdType="pii">S2405-8440(23)03719-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chang X., Ismail N.I., Rahman A., et al. Long COVID-19 and the heart: is cardiac mitochondria the missing link? Antioxid Redox Signal. 2023;38(7&#x2013;9):599&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10025846</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous A.G., 3rd, Rooks B.J., Orlando F.A. The impact of initial COVID-19 episode inflammation among adults on mortality within 12 Months post-hospital discharge. Front. Med. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135460</ArticleId><ArticleId IdType="pubmed">35646997</ArticleId></ArticleIdList></Reference><Reference><Citation>Uruha A., Nishikawa A., Tsuburaya R.S., et al. Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology. 2017;88(5):493&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">28039312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Charmchi Z., Seidman R.J., Anziska Y., Velayudhan V., Perk J. COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62(3):E57&#x2013;E60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanboon J., Nishino I. COVID-19-associated myositis may be dermatomyositis. Muscle Nerve. 2021;63(1):E9&#x2013;E10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095493</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzer M.T., Krusche M., Ruffer N., et al. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review. Rheumatol. Int. 2022;42(12):2267&#x2013;2276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9358381</ArticleId><ArticleId IdType="pubmed">35939078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Wang Q., Wang Y., et al. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720853</ArticleId><ArticleId IdType="pubmed">34987516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V., Ugel S., Tinazzi E., et al. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J. Clin. Invest. 2020;130(12):6409&#x2013;6416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016181</ArticleId><ArticleId IdType="pubmed">32809969</ArticleId></ArticleIdList></Reference><Reference><Citation>Othenin-Girard A., Regamey J., Lamoth F., et al. Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult. Swiss Med. Wkly. 2020;150</Citation><ArticleIdList><ArticleId IdType="pubmed">33181855</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>